sulfites has been researched along with Prostatic Neoplasms in 14 studies
Sulfites: Inorganic salts of sulfurous acid.
sulfites : Any sulfurous acid derivative that is a salt or an ester of sulfurous acid.
organosulfonate oxoanion : An organic anion obtained by deprotonation of the sufonate group(s) of any organosulfonic acid.
sulfite : A sulfur oxoanion that is the conjugate base of hydrogen sulfite (H2SO3).
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
Excerpt | Relevance | Reference |
---|---|---|
"We identified 1420 DMRs associated with prostate cancer-specific mortality (PCSM), which showed enrichment for gene sets downregulated in prostate cancer and de novo methylated in cancer." | 1.72 | Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality. ( Clark, SJ; Daly, RJ; Horvath, LG; Kench, JG; Korbie, D; Lam, D; Luu, PL; Peters, TJ; Pidsley, R; Qu, W; Stirzaker, C; Stricker, P, 2022) |
"CYP1A1 levels are thus increased in prostate cancer and to determine the functional effect of CYP1A1 on cells, we depleted the gene in LNCaP and DU145 by siRNA." | 1.43 | Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. ( Chang, I; Dahiya, R; Deng, G; Fukuhara, S; Hashimoto, Y; Imai-Sumida, M; Kato, T; Majid, S; Mitsui, Y; Nakajima, K; Saini, S; Shiina, H; Shiina, M; Tanaka, Y; Wong, DK; Yamamura, S, 2016) |
"This formamide-based method was applied to 46 formalin-fixed/paraffin-embedded (FFPE) biopsy tissue specimens from well-characterized patients with primary prostate cancer." | 1.35 | Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens. ( Barker, MA; Boyd, VL; Groshen, S; Imam, SA; Jones, LW; Kaur, P; Zon, G, 2009) |
"Expression of the KAI1 gene, a metastasis-suppressor for prostate cancer, is reduced in all foci of prostatic metastasis." | 1.31 | Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. ( Akakura, K; Ichikawa, T; Igarashi, T; Ito, H; Kito, H; Nakayama, T; Sekita, N; Shiraishi, T; Suzuki, H; Toyota, M; Watanabe, M; Yoshie, O, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Pidsley, R | 1 |
Lam, D | 1 |
Qu, W | 1 |
Peters, TJ | 1 |
Luu, PL | 1 |
Korbie, D | 1 |
Stirzaker, C | 2 |
Daly, RJ | 1 |
Stricker, P | 1 |
Kench, JG | 1 |
Horvath, LG | 1 |
Clark, SJ | 3 |
Hu, K | 1 |
Ting, AH | 1 |
Li, J | 1 |
Mitsui, Y | 1 |
Chang, I | 1 |
Kato, T | 1 |
Hashimoto, Y | 1 |
Yamamura, S | 1 |
Fukuhara, S | 1 |
Wong, DK | 1 |
Shiina, M | 1 |
Imai-Sumida, M | 1 |
Majid, S | 1 |
Saini, S | 1 |
Shiina, H | 1 |
Nakajima, K | 1 |
Deng, G | 1 |
Dahiya, R | 1 |
Tanaka, Y | 1 |
Schmidt, T | 1 |
Leha, A | 1 |
Salinas-Riester, G | 1 |
Zon, G | 1 |
Barker, MA | 1 |
Kaur, P | 1 |
Groshen, S | 1 |
Jones, LW | 1 |
Imam, SA | 1 |
Boyd, VL | 1 |
Statham, AL | 1 |
Robinson, MD | 1 |
Song, JZ | 1 |
Coolen, MW | 1 |
Brothman, AR | 1 |
Cui, J | 1 |
Millar, DS | 1 |
Molloy, P | 1 |
Pakneshan, P | 1 |
Xing, RH | 1 |
Rabbani, SA | 1 |
Yamada, Y | 1 |
Watanabe, M | 2 |
Yamanaka, M | 1 |
Hirokawa, Y | 1 |
Suzuki, H | 2 |
Takagi, A | 1 |
Matsuzaki, T | 1 |
Sugimura, Y | 1 |
Yatani, R | 1 |
Shiraishi, T | 2 |
Gonzalgo, ML | 1 |
Pavlovich, CP | 1 |
Lee, SM | 1 |
Nelson, WG | 1 |
Jerónimo, C | 1 |
Henrique, R | 1 |
Hoque, MO | 1 |
Ribeiro, FR | 1 |
Oliveira, J | 1 |
Fonseca, D | 1 |
Teixeira, MR | 1 |
Lopes, C | 1 |
Sidransky, D | 1 |
Sekita, N | 1 |
Ichikawa, T | 1 |
Kito, H | 1 |
Akakura, K | 1 |
Igarashi, T | 1 |
Nakayama, T | 1 |
Toyota, M | 1 |
Yoshie, O | 1 |
Ito, H | 1 |
Fukuhara, H | 1 |
Kuramochi, M | 1 |
Fukami, T | 1 |
Kasahara, K | 1 |
Furuhata, M | 1 |
Nobukuni, T | 1 |
Maruyama, T | 1 |
Isogai, K | 1 |
Sekiya, T | 1 |
Shuin, T | 1 |
Kitamura, T | 1 |
Reeves, RH | 1 |
Murakami, Y | 1 |
14 other studies available for sulfites and Prostatic Neoplasms
Article | Year |
---|---|
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality.
Topics: ADP Ribose Transferases; DNA; Epigenesis, Genetic; Epigenome; Humans; Male; Prognosis; Prostatic Neo | 2022 |
BSPAT: a fast online tool for DNA methylation co-occurrence pattern analysis based on high-throughput bisulfite sequencing data.
Topics: Base Sequence; Cell Line, Tumor; DNA Methylation; Genomics; High-Throughput Nucleotide Sequencing; H | 2015 |
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
Topics: Aged; Aged, 80 and over; Apoptosis; Azacitidine; Cell Line, Tumor; CpG Islands; Cytochrome P-450 CYP | 2016 |
Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles.
Topics: Cell Movement; Cell Proliferation; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neo | 2016 |
Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Topics: Base Sequence; Biomarkers, Tumor; Biopsy; DNA Methylation; DNA, Neoplasm; Formaldehyde; Formamides; | 2009 |
Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA.
Topics: Alleles; Cell Line; Chromatin; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; Epigenes | 2012 |
Methylation in gene promoters: assessment after laser capture microdissection.
Topics: Base Sequence; Caveolin 1; Caveolins; Cell Separation; DNA Methylation; DNA Primers; DNA, Neoplasm; | 2002 |
Bisulfite methylation analysis of tumor suppressor genes in prostate cancer from fresh and archival tissue samples.
Topics: Base Sequence; Blotting, Southern; CpG Islands; DNA Methylation; DNA, Neoplasm; Gene Expression; Gen | 2003 |
Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
Topics: Animals; Base Sequence; Blotting, Southern; Cell Division; Cytosine; DNA Methylation; Gene Expressio | 2003 |
Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene E | 2003 |
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Topics: Aged; Aged, 80 and over; Biopsy; Cohort Studies; DNA; DNA Methylation; Glutathione S-Transferase pi; | 2003 |
Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.
Topics: Adult; Aged; Biomarkers, Tumor; Disease Progression; DNA Methylation; Humans; Male; Middle Aged; Pro | 2004 |
Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Topics: Adenocarcinoma; Antigens, CD; Azacitidine; Base Sequence; Decitabine; DNA (Cytosine-5-)-Methyltransf | 2001 |
Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.
Topics: Animals; Base Sequence; Blotting, Northern; Cell Adhesion Molecule-1; Cell Adhesion Molecules; CpG I | 2002 |